CYCLERION THERAPEUTICS INC (CYCN) Stock Income Statement
NASDAQ:CYCN - Nasdaq - US23255M2044 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.08M | 2.00M | 0.00 | 1.63M | 3.94M | |||
| Operating Expenses | 5.55M | 5.63M | 9.65M | 46.00M | 58.25M | |||
| Research and Development | 278.00K | 286.00K | 1.51M | 31.49M | 37.64M | |||
| Selling, General, and Administrative Expenses | 5.27M | 5.34M | 8.13M | 14.50M | 20.62M | |||
| Operating Income | -3.47M | -3.63M | -9.65M | -44.37M | -54.31M | |||
| Interest Income/Expense | 160.00K | 208.00K | 358.00K | 290.00K | -20.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | 0.00 | |||
| Non Recurring Items | N/A | 363.00K | -3.30M | 0.00 | 2.68M | |||
| Income Before Taxes | -2.94M | -3.06M | -12.59M | -44.08M | -51.65M | |||
| Income Tax | N/A | 0.00 | N/A | N/A | N/A | |||
| Net Income | -2.94M | -3.06M | -5.26M | -44.08M | -51.65M | |||
| EBITDA | N/A | N/A | N/A | -44.30M | -53.84M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.16 | -1.21 | -2.25 | -20.31 | -26.35 | |||
| Non GAAP EPS | N/A | N/A | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Profit Margin | -141.47% | -152.85% | N/A | -2704.29% | -1310.91% | |||
| Operating Profit Margin | -166.60% | -181.40% | N/A | -2722.09% | -1378.43% | |||
All data in USD